eFFECTOR Therapeutics, Inc.
EFTR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $26 | $18 | $334 | $149 |
| - Cash | $15 | $9 | $50 | $15 |
| + Debt | $21 | $20 | $20 | $13 |
| Enterprise Value | $31 | $29 | $305 | $147 |
| Revenue | $0 | $4 | $1 | $42 |
| % Growth | -100% | 148.5% | -96.6% | – |
| Gross Profit | -$0 | $4 | $1 | $42 |
| % Margin | – | 98.5% | 98.3% | 100% |
| EBITDA | -$33 | -$20 | $18 | $16 |
| % Margin | – | -573.1% | 1,229.8% | 38.2% |
| Net Income | -$36 | -$13 | $16 | $14 |
| % Margin | – | -363.8% | 1,104.8% | 33.8% |
| EPS Diluted | -16.37 | -7.85 | 9.78 | 0.1 |
| % Growth | -108.5% | -180.3% | 9,680% | – |
| Operating Cash Flow | -$30 | -$26 | -$25 | $14 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$30 | -$26 | -$25 | $14 |